See more : Pyxis Oncology, Inc. (PYXS) Income Statement Analysis – Financial Results
Complete financial analysis of Ami Organics Limited (AMIORG.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ami Organics Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Sansha Electric Manufacturing Co.,Ltd. (6882.T) Income Statement Analysis – Financial Results
- Jackson Financial Inc. (JXNFL) Income Statement Analysis – Financial Results
- Advanced Energy Solution Holding Co., Ltd. (6781.TW) Income Statement Analysis – Financial Results
- Qinghai Jinrui Mineral Development Co., Ltd (600714.SS) Income Statement Analysis – Financial Results
- Siemens Healthineers AG (SHL.DE) Income Statement Analysis – Financial Results
Ami Organics Limited (AMIORG.BO)
About Ami Organics Limited
Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers approximately 520 pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries. In addition, the company exports its products. Ami Organics Limited was founded in 2004 and is based in Surat, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.13B | 6.17B | 5.20B | 3.36B | 2.40B | 2.39B | 1.84B | 1.56B | 1.53B |
| Cost of Revenue | 5.60B | 3.31B | 2.73B | 2.19B | 1.62B | 1.65B | 1.43B | 1.17B | 1.13B |
| Gross Profit | 1.53B | 2.86B | 2.47B | 1.18B | 776.58M | 735.88M | 401.32M | 383.22M | 398.82M |
| Gross Profit Ratio | 21.53% | 46.35% | 47.55% | 34.97% | 32.41% | 30.85% | 21.86% | 24.61% | 26.09% |
| Research & Development | 102.48M | 64.89M | 1.23M | 6.66M | 21.46M | 18.10M | 24.50M | 27.79M | 20.00M |
| General & Administrative | 71.81M | 0.00 | 43.75M | 21.22M | 30.07M | 33.73M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 146.75M | 0.00 | 202.56M | 70.08M | 57.57M | 60.35M | 0.00 | 0.00 | 0.00 |
| SG&A | 218.56M | 403.84M | 246.31M | 91.30M | 87.64M | 94.08M | 98.04M | 83.73M | 94.82M |
| Other Expenses | 74.91M | 43.20M | 27.62M | 3.62M | 15.19M | 3.47M | -36.27M | -99.10M | -117.86M |
| Operating Expenses | 2.58B | 1.76B | 1.52B | 411.47M | 393.94M | 315.06M | 158.81M | 210.62M | 232.68M |
| Cost & Expenses | 6.03B | 5.06B | 4.25B | 2.60B | 2.01B | 1.96B | 1.59B | 1.38B | 1.36B |
| Interest Income | 21.32M | 21.79M | 25.82M | 1.95M | 940.00K | 370.00K | 2.14M | 310.00K | 540.00K |
| Interest Expense | 59.40M | 24.12M | 64.07M | 52.00M | 53.75M | 46.57M | 32.25M | 32.95M | 25.59M |
| Depreciation & Amortization | 160.55M | 123.42M | 100.80M | 41.88M | 35.18M | 26.00M | 19.05M | 13.68M | 7.99M |
| EBITDA | 1.04B | 1.27B | 1.08B | 814.47M | 438.14M | 424.40M | 334.76M | 186.28M | 174.13M |
| EBITDA Ratio | 14.57% | 20.58% | 20.75% | 24.26% | 18.45% | 17.84% | 14.25% | 11.96% | 11.39% |
| Operating Income | 1.14B | 1.12B | 960.56M | 726.60M | 351.21M | 375.79M | 242.51M | 172.60M | 166.14M |
| Operating Income Ratio | 16.03% | 18.23% | 18.47% | 21.61% | 14.66% | 15.76% | 13.21% | 11.09% | 10.87% |
| Total Other Income/Expenses | -323.70M | -2.33M | -46.05M | -9.34M | -35.10M | -69.72M | 40.95M | 14.22M | 10.86M |
| Income Before Tax | 819.01M | 1.12B | 914.50M | 717.26M | 347.54M | 351.10M | 283.46M | 186.82M | 177.00M |
| Income Before Tax Ratio | 11.49% | 18.19% | 17.58% | 21.33% | 14.50% | 14.72% | 15.44% | 12.00% | 11.58% |
| Income Tax Expense | 331.93M | 288.82M | 195.04M | 177.27M | 72.84M | 118.15M | 98.51M | 66.34M | 50.44M |
| Net Income | 427.73M | 832.90M | 719.46M | 539.99M | 274.70M | 232.95M | 184.95M | 120.48M | 126.56M |
| Net Income Ratio | 6.00% | 13.50% | 13.83% | 16.06% | 11.46% | 9.77% | 10.08% | 7.74% | 8.28% |
| EPS | 11.60 | 22.86 | 21.03 | 17.14 | 8.72 | 6.39 | 13.21 | 8.61 | 9.04 |
| EPS Diluted | 11.66 | 22.86 | 21.03 | 17.14 | 8.72 | 6.39 | 13.21 | 8.61 | 9.04 |
| Weighted Avg Shares Out | 36.88M | 36.44M | 34.21M | 31.50M | 31.50M | 36.44M | 14.00M | 14.00M | 14.00M |
| Weighted Avg Shares Out (Dil) | 36.68M | 36.44M | 34.21M | 31.50M | 31.50M | 36.44M | 14.00M | 14.00M | 14.00M |
Source: https://incomestatements.info
Category: Stock Reports